Key Takeaways DGX stock jumped 27.3% over 12 months, far exceeding the industry and the benchmark's performance. Quest Diagnostics' strength in Advanced Diagnostics supports growth across high-demand medical categories. New health plan deals and lab partnerships are expanding DGX's reach and boosting volume and revenue.Quest Diagnostics (DGX) has shown impressive momentum in the past year, with its shares rallying 27.3%. The performance outpaces the industry’s 5.9% rise and the S&P 500 composite’s 12.3% g ...

Quest Diagnostics (DGX) FY Conference June 03, 2025 11:00 AM ET Speaker0 Thanks again for joining us at this year's William Blair Growth Stock Conference. This morning, we're very pleased to have the team from Quest Diagnostics joining us here. We have the CEO, Jim Davis from Investor Relations, Sean Bevek here in the front row. Format for today will be a thirty minute presentation in this room, then we'll go to the breakout afterwards, which is an ad in the Adler Room on the Second Floor. And then for comp ...

BURLINGTON, N.C., May 8, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 15 at 9:00 a.m. ET and can be viewed online on the Labcorp Investor Relations website. An archived replay of the webcast will be available for one year.About LabcorpLabcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmac ...